GAMMA Investing LLC Has $225,000 Holdings in USANA Health Sciences, Inc. (NYSE:USNA)

GAMMA Investing LLC increased its stake in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 49,082.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 8,361 shares of the company's stock after purchasing an additional 8,344 shares during the period. GAMMA Investing LLC's holdings in USANA Health Sciences were worth $225,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Pzena Investment Management LLC boosted its stake in USANA Health Sciences by 3.6% in the 4th quarter. Pzena Investment Management LLC now owns 1,087,076 shares of the company's stock worth $39,015,000 after purchasing an additional 37,466 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of USANA Health Sciences by 7.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 773,228 shares of the company's stock worth $27,751,000 after buying an additional 55,059 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of USANA Health Sciences by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 301,949 shares of the company's stock worth $10,839,000 after buying an additional 4,829 shares during the last quarter. American Century Companies Inc. boosted its stake in shares of USANA Health Sciences by 12.3% during the 4th quarter. American Century Companies Inc. now owns 233,797 shares of the company's stock worth $8,391,000 after buying an additional 25,522 shares during the last quarter. Finally, Northern Trust Corp boosted its stake in shares of USANA Health Sciences by 16.5% during the 4th quarter. Northern Trust Corp now owns 135,937 shares of the company's stock worth $4,879,000 after buying an additional 19,266 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently commented on USNA shares. Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd. DA Davidson reduced their price objective on shares of USANA Health Sciences from $38.00 to $36.00 and set a "neutral" rating for the company in a research note on Thursday, February 27th.

USANA Health Sciences Price Performance

USANA Health Sciences stock opened at $30.57 on Friday. The firm has a 50-day moving average of $28.60 and a 200-day moving average of $30.80. USANA Health Sciences, Inc. has a one year low of $23.10 and a one year high of $48.85. The company has a market cap of $569.14 million, a price-to-earnings ratio of 16.79, a P/E/G ratio of 0.98 and a beta of 0.63.

USANA Health Sciences (NYSE:USNA - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.70 by $0.03. The company had revenue of $249.54 million for the quarter, compared to analysts' expectations of $243.08 million. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. During the same period in the prior year, the firm earned $0.86 EPS. As a group, sell-side analysts expect that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Insider Activity

In other USANA Health Sciences news, CFO G Doug Iiekking sold 4,548 shares of the stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total value of $134,666.28. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction dated Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total transaction of $190,554.39. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,013 shares of company stock valued at $360,149. 0.63% of the stock is owned by company insiders.

USANA Health Sciences Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.